跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BY-03
首页
药物
BY-03
BY-03
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Lactobacillus rhamnosus CL-03-containing probiotic agent for relieving eczema as well as preparation method and application of lactobacillus rhamnosus CL-03-containing probiotic agent
申请人: KASHI DAIRY SHENZHEN CO LTD
优先权: 2026
CN
Application of small-molecule inhibitor MYF-03-176 in preparation of medicine for treating and/or preventing keloid and medicine
申请人: FIRST AFFILIATED HOSPITAL MEDICAL COLLEGE XIAN JIAOTONG UNIV
优先权: 2026
CN
Application of small-molecule inhibitor MYF-03-69 in preparation of medicine for treating and/or preventing keloid
申请人: FIRST AFFILIATED HOSPITAL MEDICAL COLLEGE XIAN JIAOTONG UNIV
优先权: 2026
CN
Application of lactobacillus acidophilus LA-03 in preparation of medicine for preventing or treating intestinal inflammation
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
Application of lactobacillus acidophilus LA-03 in preparation of antioxidant and anti-aging products
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
Application of HLA allele in preparation of detection kit for screening adrenocortical hypofunction high-risk population
申请人: ZHONGSHAN HOSPITAL FUDAN UNIV
优先权: 2024
CN
Application of lactobacillus acidophilus LA-03 in preparation of medicine for treating or preventing diabetes
申请人: GUANGDONG LONGSEE MEDICAL TECH CO LTD
优先权: 2023
CN
Preparation method of ezetimibe optical isomer
申请人: LUOXIN PHARMACEUTICAL (SHANGHAI) CO LTD
优先权: 2018
CN
药物
反馈